...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Synthorx and RVX

Sanofi today said they would buy Synthorx (THOR US) for $2.5 billion in cash; oncology related. 

In my search to justify a US$2 billion market cap for RVX, this buyout is the most encouraging sign yet, that RVX will get a high price; at least as high as $2.5 billion. 

THOR was trading at $11 (US$330 million market cap) on October 28 2019 and the buyout share price is $68...6 times up.  That is about as close as you can get for RVX.  Hopefully, this breathes fresh life into RVX share price.

Here's hoping!

Iconoclast 

Share
New Message
Please login to post a reply